Our results are in line with other studies that have identified both CD10low CXCR2high neutrophil subsets in severe COVID-19 by RNA sequencing (14) and reduced CXCR2 expression in moderately ill patients (78). This evidence concerns the gene CXCR2 and COVID-19.